Esperion Therapeutics
ESPR
#6745
Rank
A$1.15 B
Marketcap
A$4.47
Share price
0.00%
Change (1 day)
21.21%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2026 (TTM): A$0.11 Billion

According to Esperion Therapeutics's latest financial reports the company's current earnings are A$0.41 Billion. In 2025 the company made an earning of A$89.53 Million, an increase over its 2024 earnings that were of A$10.53 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.11 B32.7%
2025 A$89.53 M749.49%
2024 A$10.53 M-104.99%
2023 -A$0.22 Billion-15.03%
2022 -A$0.25 Billion-20.61%
2021 -A$0.32 Billion84.28%
2020 -A$0.17 Billion35.75%
2019 -A$0.13 Billion-55.71%
2018 -A$0.29 Billion19.57%
2017 -A$0.24 Billion125.39%
2016 -A$0.11 Billion51.43%
2015 -A$69.18 Million36.45%
2014 -A$50.7 Million43.55%
2013 -A$35.32 Million145.26%
2012 -A$14.41 Million
2002 -A$41.06 Million-7.81%
2001 -A$44.54 Million15.03%
2000 -A$38.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$14.87 B 13,240.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$7.24 B 6,395.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-A$0.76 Billion-775.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-A$36.64 Million-132.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$0.26 M-99.76%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.54 B 385.70%๐Ÿ‡บ๐Ÿ‡ธ USA